What is she best known for?
The fields of study she is best known for:
- Cancer
- Gene
- Internal medicine
Sofia D. Merajver mainly focuses on Breast cancer, Cancer research, Cancer, Pathology and Inflammatory breast cancer.
The various areas that she examines in her Breast cancer study include Gynecology and Radiation therapy.
Her research integrates issues of Oncology, Ovarian cancer, Obstetrics, Genetic testing and Risk factor in her study of Gynecology.
Her work carried out in the field of Cancer research brings together such families of science as Carcinogenesis, RhoC GTP-Binding Protein, RhoC and Transfection.
Her work on Carcinoma and Immunohistochemistry as part of her general Pathology study is frequently connected to Copper deficiency and Blood Collection Tube, thereby bridging the divide between different branches of science.
Her Inflammatory breast cancer research includes themes of End results, Gerontology, Phenotype, Immunology and Transplantation.
Her most cited work include:
- The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. (749 citations)
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. (437 citations)
- BRCA1 regulates human mammary stem/progenitor cell fate (390 citations)
What are the main themes of her work throughout her whole career to date?
Sofia D. Merajver focuses on Breast cancer, Cancer, Cancer research, Internal medicine and Oncology.
Sofia D. Merajver specializes in Breast cancer, namely Inflammatory breast cancer.
Her study explores the link between Cancer and topics such as Family medicine that cross with problems in Genetic counseling.
Sofia D. Merajver works mostly in the field of Cancer research, limiting it down to concerns involving RhoC and, occasionally, Motility.
Her Internal medicine research is multidisciplinary, relying on both Gastroenterology and Endocrinology.
Sofia D. Merajver conducted interdisciplinary study in her works that combined Oncology and Risk assessment.
She most often published in these fields:
- Breast cancer (40.21%)
- Cancer (32.38%)
- Cancer research (27.68%)
What were the highlights of her more recent work (between 2015-2021)?
- Cancer (32.38%)
- Breast cancer (40.21%)
- Cancer research (27.68%)
In recent papers she was focusing on the following fields of study:
Sofia D. Merajver mainly investigates Cancer, Breast cancer, Cancer research, Internal medicine and Oncology.
Her studies in Cancer integrate themes in fields like SNP, Computational biology and Family medicine.
Her primary area of study in Breast cancer is in the field of Inflammatory breast cancer.
In the subject of general Inflammatory breast cancer, her work in RhoC GTP-Binding Protein is often linked to North africa, thereby combining diverse domains of study.
The Cancer research study combines topics in areas such as Gene expression, Cancer cell, Triple-negative breast cancer, Drug and RhoC.
Her studies deal with areas such as Germline, Placebo, Tamoxifen, Estrogen receptor and Cohort as well as Oncology.
Between 2015 and 2021, her most popular works were:
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. (437 citations)
- Genetic/familial high-risk assessment: Breast and ovarian, version 2.2015 Featured updates to the NCCN guidelines (223 citations)
- Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes. (108 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Sofia D. Merajver spends much of her time researching Breast cancer, Cancer, Internal medicine, Oncology and Cancer research.
Her study on Metastatic breast cancer is often connected to African american as part of broader study in Breast cancer.
Her Oncology research is multidisciplinary, incorporating perspectives in Germline, Ovarian cancer, Estrogen receptor and Genetic testing.
Her Cancer research study combines topics in areas such as Cell, Cell migration, Cancer cell, Inflammatory breast cancer and RhoC.
Her Cancer cell research integrates issues from Carcinogenesis, Cancer stem cell and Primary tumor, Metastasis.
The study incorporates disciplines such as Survival pathways, Oncogene and Library science in addition to Inflammatory breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
